.
Company
Letter from the Chairman
Letter from the CEO
2021 Highlights
Financial Highlights
Investor Information
Our Strategic Priorities
Talent Management
Our Approach to the COVID-19 Pandemic
Our Businesses
Innovations in 2021
Biologics
Small Molecules
Cell & Gene
Capsules & Health Ingredients
Associates and Joint Ventures
Sustainability
Financials
Remuneration
Governance
Creating Value in 2021
Creating Value in 2021
Our Businesses
Our Approach to Sustainability
Corporate Governance Overview
Financial Statements Overview
Remuneration
Creating Value in 2021
Download Section PDF
